Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.03 +0.02 (+1.98%)
As of: Oct 21, 2026 · 3:39 PM EDT

Telomir Pharmaceuticals (TELO) Enterprise Value (2024 - 2026)

Updated

Telomir Pharmaceuticals' Enterprise Value came in at $82.83 million for Q2 2026, up 121.5% from $37.39 million a year earlier.

Analysis

Telomir Pharmaceuticals (TELO) Enterprise Value (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Telomir Pharmaceuticals reported Enterprise Value of $67.46 million, up 93.4% year-over-year; for FY2025, it came in at $38.44 million, down 68.3% from FY2024.

  • Going back by year, Enterprise Value was $121.36 million in FY2024.
  • The Q2 2026 figure represents the highest quarterly Enterprise Value since Q1 2025.
  • Year-over-year, Enterprise Value increased in 1 of the last five quarters, with an average decline of 27.0%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.42 Bn 1,106.00 Bn 19.71 Bn
2 Johnson & Johnson 617.98 Bn 536.51 Bn 17.26 Bn
3 AbbVie 502.80 Bn 475.92 Bn 12.70 Bn
4 Merck 368.67 Bn 323.05 Bn 12.21 Bn
5 Novartis Ag 298.36 Bn 262.35 Bn 11.24 Bn
6 Astrazeneca 261.17 Bn 234.85 Bn 12.86 Bn
7 Amgen 237.18 Bn 192.58 Bn 7.24 Bn
8 Gilead Sciences 191.11 Bn 165.31 Bn 6.22 Bn
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn
10 Telomir Pharmaceuticals 62.97 Mn 42.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 82.83 Mn
Dec 31, 2025 38.44 Mn
Sep 30, 2025 39.70 Mn
Jun 30, 2025 37.39 Mn
Mar 31, 2025 95.73 Mn
Dec 31, 2024 121.36 Mn
Sep 30, 2024 189.26 Mn
Jun 30, 2024 140.52 Mn
Mar 31, 2024 149.19 Mn
API Access

Telomir Pharmaceuticals Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=TELO&period=max&api_key=YOUR_API_KEY